Market Overview

Why Mustang Bio's Stock Is Trading Lower Today


Mustang Bio, Inc. (NASDAQ: MBIO) shares are trading lower after the company announced a common stock offering of 10.769 million shares at $3.25 per share.

The company announced it intends to use the net proceeds from the offering primarily for the continued development of its product candidates, the potential in-license, acquisition, development and commercialization of other pharmaceutical products and for general corporate purposes.

Mustang Bio is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases.

Mustang Bio's stock was trading down 26.96% at $3.36 on Thursday at the time of publication. The company has a 52-week high of $4.85 and a 52-week low of $1.78.


Related Articles (MBIO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Offerings

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at